Vergoeding 2019-2023 voor ATC-subgroep N06BA : Centraalwerkende sympathicomimetica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N06BA02 Dexamfetamine (Tentin ®) | 12.102.100 | 16.222.700 | 16.744.600 | 20.380.000 | 23.681.200 |
| N06BA04 Methylfenidaat (Medikinet ®) | 19.333.500 | 18.489.000 | 19.704.600 | 22.281.700 | 22.531.500 |
| N06BA07 Modafinil (Modiodal ®) | 326.470 | 412.550 | 284.350 | 524.970 | 733.160 |
| N06BA09 Atomoxetine (Strattera ®) | 2.115.500 | 1.070.300 | 700.250 | 662.920 | 486.020 |
| N06BA12 Lisdexamfetamine (Elvanse ®) | 413.540 | 5.174.500 | 8.391.500 | 11.507.500 | 14.515.600 |
| N06BA14 Solriamfetol (Sunosi ®) | . | . | . | . | 9.236 |
| Totaal | 34.291.110 | 41.369.050 | 45.825.300 | 55.357.090 | 61.956.716 |